157 related articles for article (PubMed ID: 11801660)
1. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket.
Suri A; Vidavsky I; van der Drift K; Kanagawa O; Gross ML; Unanue ER
J Immunol; 2002 Feb; 168(3):1235-43. PubMed ID: 11801660
[TBL] [Abstract][Full Text] [Related]
2. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
Suri A; Walters JJ; Gross ML; Unanue ER
J Clin Invest; 2005 Aug; 115(8):2268-76. PubMed ID: 16075062
[TBL] [Abstract][Full Text] [Related]
3. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules.
Suri A; Walters JJ; Rohrs HW; Gross ML; Unanue ER
J Immunol; 2008 Mar; 180(6):3849-56. PubMed ID: 18322192
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
Latek RR; Suri A; Petzold SJ; Nelson CA; Kanagawa O; Unanue ER; Fremont DH
Immunity; 2000 Jun; 12(6):699-710. PubMed ID: 10894169
[TBL] [Abstract][Full Text] [Related]
5. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
6. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.
Stratmann T; Apostolopoulos V; Mallet-Designe V; Corper AL; Scott CA; Wilson IA; Kang AS; Teyton L
J Immunol; 2000 Sep; 165(6):3214-25. PubMed ID: 10975837
[TBL] [Abstract][Full Text] [Related]
7. Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).
Münz C; Hofmann M; Yoshida K; Moustakas AK; Kikutani H; Stevanoviç S; Papadopoulos GK; Rammensee HG
Eur J Immunol; 2002 Aug; 32(8):2105-16. PubMed ID: 12209622
[TBL] [Abstract][Full Text] [Related]
8. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
[TBL] [Abstract][Full Text] [Related]
9. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell.
Nelson CA; Petzold SJ; Unanue ER
Nature; 1994 Sep; 371(6494):250-2. PubMed ID: 8078585
[TBL] [Abstract][Full Text] [Related]
10. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
Gardiner A; Richards KA; Sant AJ; Arneson LS
Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
Parras D; Solé P; Delong T; Santamaría P; Serra P
Front Immunol; 2021; 12():737428. PubMed ID: 34527002
[TBL] [Abstract][Full Text] [Related]
12. Independent selection by I-Ak molecules of two epitopes found in tandem in an extended polypeptide antigen.
Gugasyan R; Velazquez C; Vidavsky I; Deck BM; van der Drift K; Gross ML; Unanue ER
J Immunol; 2000 Sep; 165(6):3206-13. PubMed ID: 10975836
[TBL] [Abstract][Full Text] [Related]
13. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
14. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of lysozyme peptides bound to class II MHC molecules indicates very large differences in levels of presentation.
Velazquez C; DiPaolo R; Unanue ER
J Immunol; 2001 May; 166(9):5488-94. PubMed ID: 11313387
[TBL] [Abstract][Full Text] [Related]
16. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
[TBL] [Abstract][Full Text] [Related]
17. pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH.
Hausmann DH; Yu B; Hausmann S; Wucherpfennig KW
J Exp Med; 1999 Jun; 189(11):1723-34. PubMed ID: 10359576
[TBL] [Abstract][Full Text] [Related]
18. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
19. APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells.
Lovitch SB; Walters JJ; Gross ML; Unanue ER
J Immunol; 2003 Apr; 170(8):4155-60. PubMed ID: 12682247
[TBL] [Abstract][Full Text] [Related]
20. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
